Product Information
SIROLIMUS 2 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $2.6413 per EA under NDC 67877074801. Its NADAC has been published 149 times since Oct 18, 2023.
FDA first approved this application on Mar 12, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877074801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SIROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA214753FDA Approved
3/12/2021
TE Code
AB
On Market Since
3/13/2021
Pharmacological Classes
Price Statistics
The NADAC for SIROLIMUS 2 MG TABLET has been published 149 times since Oct 18, 2023, and over the history we have for it it has declined 30.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6413 per EA |
|---|---|
| All-time high | $6.0804 (Aug 13, 2025) |
| All-time low | $2.6413 (Aug 19, 2026) |
| 52-week high | $5.8001 |
| 52-week low | $2.6413 |
| Median price | $4.4680 |
| Average price | $4.4545 |
| Largest weekly change | +29.7% (Dec 13, 2023) |
| Weeks tracked | 149 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SIROLIMUS 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 2 MG TABLET, manufactured by Ascend Laboratories, LLC, is $2.6413 per EA (NDC 67877074801), effective Aug 19, 2026.
How has the price of SIROLIMUS 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIROLIMUS 2 MG TABLET has declined 30.6%. It has been tracked across 149 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for SIROLIMUS 2 MG TABLET?
Since Oct 18, 2023, the NADAC for SIROLIMUS 2 MG TABLET has ranged from a low of $2.6413 (Aug 19, 2026) to a high of $6.0804 (Aug 13, 2025), with a median of $4.4680 per EA.
Are there cheaper alternatives to SIROLIMUS 2 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SIROLIMUS 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SIROLIMUS 2 MG TABLET?
SIROLIMUS 2 MG TABLET (NDC 67877074801) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.